BASF Intensifies Cost-Cutting Strategy Amid Challenging Outlook
07.03.2026 - 06:06:11 | boerse-global.deThe German chemical giant BASF has announced a significant escalation of its austerity measures. The company now aims to achieve annual cost savings of 2.3 billion euros by the end of 2026, a sharp increase from its previous target of 1.6 billion euros. This decision comes as management anticipates no meaningful recovery in the current year, with its official forecast falling short of prevailing market expectations.
Financial Performance and Cautious Guidance
The company's 2025 fiscal year delivered disappointing results. Earnings before interest, taxes, depreciation, and amortization (EBITDA) before special items declined by 9.5 percent to 6.6 billion euros. Adjusted EBIT experienced a more severe contraction, dropping 18.1 percent. Group sales receded to just under 60 billion euros.
Looking ahead to 2026, CEO Markus Kamieth provided an EBITDA guidance range of 6.2 to 7.0 billion euros. The midpoint of this projection sits below the estimates of many market analysts. BASF's leadership does not foresee a near-term economic upturn or a reduction in ongoing geopolitical tensions, contributing to its restrained outlook.
A persistent concern is cash flow generation. The company is projecting free cash flow between 1.5 and 2.3 billion euros for the coming period. This follows a 2025 result of only 1.34 billion euros, which was insufficient to fully cover the dividend payout of 2.25 euros per share.
Drastic Operational Measures
In response to the strained environment, BASF is implementing rigorous operational changes. A workforce reduction program, which has already eliminated 4,800 positions since late 2023, will be extended with additional cuts in administrative and IT functions. Furthermore, the corporation is shifting certain operational roles to India and Malaysia.
Capital expenditure is also facing deep cuts. BASF plans to reduce its intended investments for the period 2026 through 2029 by 20 percent, lowering the budget to 13 billion euros.
Should investors sell immediately? Or is it worth buying BASF?
Strategic Portfolio Reshaping and Share Buybacks
Parallel to its cost-cutting drive, BASF is actively reshaping its business portfolio through divestments. The sale of its optical brighteners business to Catexel was finalized in late February. Plans are underway to divest the coatings division in the second quarter of 2026, while the agricultural solutions segment is being prepared for a potential initial public offering by 2027.
Simultaneously, the company is returning capital to shareholders through a substantial buyback initiative. A program authorizing the repurchase of up to 1.5 billion euros in stock is active until the end of June 2026. Since its launch in November 2025, BASF has already bought back 14 million of its own shares, including approximately 673,000 in the final week of February alone.
Mixed Signals from Chinese Venture
The company's major new integrated site in Zhanjiang, China, represents a key strategic investment. BASF has reported the successful commissioning of the facility's core plants. However, this expansion faces headwinds from falling prices and substantial overcapacity in the Chinese market.
Analyst perspectives on the stock remain divided. In early March, Berenberg upgraded its rating from "Sell" to "Hold," while J.P. Morgan maintains a "Sell" recommendation. Goldman Sachs, in contrast, assigns a "Buy" rating. Shareholders will be keenly focused on updates regarding the savings program at the upcoming Annual Meeting, scheduled for April 30, 2026, in Mannheim.
Ad
BASF Stock: New Analysis - 7 March
Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis BASF Aktien ein!
Für. Immer. Kostenlos.

